Research suggests that these drugs may reduce the risk of heart attack, stroke, and other cardiovascular issues even for ...
An obesity drug could cut heart disease and stroke risks even if you don’t lose any weight. New research has shown that ...
The drug Wegovy uses an active ingredient called Semaglutide, which is part of a growing class of GLP-1 drugs that make ...
Semaglutide, also known as Ozempic or Wegovy, is set to transform treatments for cardiovascular disease, but a change in ...
A groundbreaking study has revealed that an anti-obesity jab containing semaglutide, a drug used to treat obesity, significantly reduces the risk of heart attacks and strokes, regardless of the amount ...
Anti-obesity jabs could reduce the risk of heart attacks, strokes or heart failure in obese people regardless of the amount ...
Jabs designed to combat obesity might lower the likelihood of heart attacks, strokes, or heart failure among obese ...
Injections of a weight loss drug could be a ‘game changer’ for cardiovascular patients by cutting the risk of heart attacks or strokes.
The popular drug Wegovy also is found to reduce the risk of strokes and heart attacks in patients no matter how much they weighed, a new study concludes.
Trials of a weight-loss drug which could cut the risk of heart attacks and strokes by a fifth feature heavily as a range of stories compete for attention on Tuesday’s newspaper front pages. The Times ...
Kelly Clarkson has confirmed she has been taking weight loss medication, but denied it is the high profile drug Ozempic. The ...